Speaker Profile
Biography
Patrick Brannelly has over 20 years of experience building groundbreaking neuroscience initiatives. Most recently, he was a member of the Health & Life Sciences team at Gates Ventures, where he served as Director of Partnerships & Business Development for the nonprofit Alzheimer’s Disease Data Initiative. Prior to this, he was Managing Director of the Rainwater Charitable Foundation’s Tau Consortium, which seeks to accelerate the development of new treatments for Alzheimer’s disease and frontotemporal dementia.
Earlier in his career, Pat was co-founder and CEO of NeoCORTA and Director of Partnerships & Group Programs at Posit Science, both early-stage brain health technology ventures. He also served as a management consultant in the U.S. and Europe across the pharmaceutical, energy, and technology sectors. He currently serves as a Board member and Treasurer for Stroke Onward and Harvard Alumni in Healthcare, and is a former Assistant Professor of Entrepreneurship at California State University, Fresno.
Session Abstract – PMWC 2027 Silicon Valley
Davos of Precision Medicine
PMWC 2027 Program
January 27–29, 2027 · Santa Clara Convention Center
Swipe speakers · Tap a card for sessions →
In a few words.
PMWC is indeed The Davos of Biotech
Day 1 / Wed · Jan 27
Day 2 / Thu · Jan 28
Day 3 / Fri · Jan 29
PMWC Hall of Impact
Previous Speakers Include
Nobel laureates, technology founders, regulators, CEOs and scientific pioneers who have taken the PMWC stage.